These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15716665)

  • 1. Lack of efficacy of a reduced microparticle diet in a multi-centred trial of patients with active Crohn's disease.
    Lomer MC; Grainger SL; Ede R; Catterall AP; Greenfield SM; Cowan RE; Vicary FR; Jenkins AP; Fidler H; Harvey RS; Ellis R; McNair A; Ainley CC; Thompson RP; Powell JJ
    Eur J Gastroenterol Hepatol; 2005 Mar; 17(3):377-84. PubMed ID: 15716665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of a low microparticle diet in a double blind, randomized, pilot study in Crohn's disease.
    Lomer MC; Harvey RS; Evans SM; Thompson RP; Powell JJ
    Eur J Gastroenterol Hepatol; 2001 Feb; 13(2):101-6. PubMed ID: 11246607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled study comparing elemental diet and steroid treatment in Crohn's disease.
    Zoli G; Carè M; Parazza M; Spanò C; Biagi PL; Bernardi M; Gasbarrini G
    Aliment Pharmacol Ther; 1997 Aug; 11(4):735-40. PubMed ID: 9305483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary sources of inorganic microparticles and their intake in healthy subjects and patients with Crohn's disease.
    Lomer MC; Hutchinson C; Volkert S; Greenfield SM; Catterall A; Thompson RP; Powell JJ
    Br J Nutr; 2004 Dec; 92(6):947-55. PubMed ID: 15613257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial enteral nutrition with a Crohn's disease exclusion diet is effective for induction of remission in children and young adults with Crohn's disease.
    Sigall-Boneh R; Pfeffer-Gik T; Segal I; Zangen T; Boaz M; Levine A
    Inflamm Bowel Dis; 2014 Aug; 20(8):1353-60. PubMed ID: 24983973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Study Group Members (German Crohn's Disease Study Group).
    Lorenz-Meyer H; Bauer P; Nicolay C; Schulz B; Purrmann J; Fleig WE; Scheurlen C; Koop I; Pudel V; Carr L
    Scand J Gastroenterol; 1996 Aug; 31(8):778-85. PubMed ID: 8858747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fine and ultrafine particles of the diet: influence on the mucosal immune response and association with Crohn's disease.
    Lomer MC; Thompson RP; Powell JJ
    Proc Nutr Soc; 2002 Feb; 61(1):123-30. PubMed ID: 12002786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low dose naltrexone for induction of remission in Crohn's disease.
    Segal D; Macdonald JK; Chande N
    Cochrane Database Syst Rev; 2014 Feb; (2):CD010410. PubMed ID: 24558033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study.
    Feagan BG; Sandborn WJ; D'Haens G; Panés J; Kaser A; Ferrante M; Louis E; Franchimont D; Dewit O; Seidler U; Kim KJ; Neurath MF; Schreiber S; Scholl P; Pamulapati C; Lalovic B; Visvanathan S; Padula SJ; Herichova I; Soaita A; Hall DB; Böcher WO
    Lancet; 2017 Apr; 389(10080):1699-1709. PubMed ID: 28411872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of provocation by foods with raised IgG antibodies and additives on the course of Crohn's disease: a pilot study.
    Uzunısmaıl H; Cengız M; Uzun H; Ozbakir F; Göksel S; Demırdağ F; Can G; Balci H
    Turk J Gastroenterol; 2012 Feb; 23(1):19-27. PubMed ID: 22505375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term efficacy of enteral nutrition in the treatment of active Crohn's disease: a randomized, controlled trial comparing nutrient formulas.
    Sakurai T; Matsui T; Yao T; Takagi Y; Hirai F; Aoyagi K; Okada M
    JPEN J Parenter Enteral Nutr; 2002; 26(2):98-103. PubMed ID: 11871742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial.
    Targan SR; Feagan BG; Fedorak RN; Lashner BA; Panaccione R; Present DH; Spehlmann ME; Rutgeerts PJ; Tulassay Z; Volfova M; Wolf DC; Hernandez C; Bornstein J; Sandborn WJ;
    Gastroenterology; 2007 May; 132(5):1672-83. PubMed ID: 17484865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial.
    Vermeire S; Schreiber S; Petryka R; Kuehbacher T; Hebuterne X; Roblin X; Klopocka M; Goldis A; Wisniewska-Jarosinska M; Baranovsky A; Sike R; Stoyanova K; Tasset C; Van der Aa A; Harrison P
    Lancet; 2017 Jan; 389(10066):266-275. PubMed ID: 27988142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn's disease.
    Akobeng AK; Miller V; Stanton J; Elbadri AM; Thomas AG
    J Pediatr Gastroenterol Nutr; 2000 Jan; 30(1):78-84. PubMed ID: 10630444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial.
    Gassull MA; Fernández-Bañares F; Cabré E; Papo M; Giaffer MH; Sánchez-Lombraña JL; Richart C; Malchow H; González-Huix F; Esteve M;
    Gut; 2002 Aug; 51(2):164-8. PubMed ID: 12117873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Crohn's Disease with an IgG4-Guided Exclusion Diet: A Randomized Controlled Trial.
    Gunasekeera V; Mendall MA; Chan D; Kumar D
    Dig Dis Sci; 2016 Apr; 61(4):1148-57. PubMed ID: 26809868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial.
    Riordan AM; Hunter JO; Cowan RE; Crampton JR; Davidson AR; Dickinson RJ; Dronfield MW; Fellows IW; Hishon S; Kerrigan GN
    Lancet; 1993 Nov; 342(8880):1131-4. PubMed ID: 7901473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of budesonide with prednisolone for active Crohn's disease.
    Rutgeerts P; Löfberg R; Malchow H; Lamers C; Olaison G; Jewell D; Danielsson A; Goebell H; Thomsen OO; Lorenz-Meyer H
    N Engl J Med; 1994 Sep; 331(13):842-5. PubMed ID: 8078530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Crohn's Disease Exclusion Diet for Induction of Remission in Crohn's Disease Adult Patients.
    Szczubełek M; Pomorska K; Korólczyk-Kowalczyk M; Lewandowski K; Kaniewska M; Rydzewska G
    Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crohn's Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial.
    Levine A; Wine E; Assa A; Sigall Boneh R; Shaoul R; Kori M; Cohen S; Peleg S; Shamaly H; On A; Millman P; Abramas L; Ziv-Baran T; Grant S; Abitbol G; Dunn KA; Bielawski JP; Van Limbergen J
    Gastroenterology; 2019 Aug; 157(2):440-450.e8. PubMed ID: 31170412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.